High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: Results from the TOLERANCE study

1. Barrios, V.
2. Escobar, C.
3. De La Figuera, M.
4. Honorato, J.
5. Llisterri, J.L.
6. Segura, J.
7. Calderón, A.